PWH
ABBV icon

Priebe Wealth Holdings’s AbbVie ABBV Stock Holding History

Priebe Wealth Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$543K Sell
2,923
-363
-11% -$67.5K 0.47% 37
2025
Q1 		$688K Buy
3,286
+200
+6% +$38.9K 0.43% 33
2024
Q4 		$548K Buy
3,086
+902
+41% +$166K 0.37% 35
2024
Q3 		$431K Hold
2,184
– – 0.31% 36
2024
Q2 		$375K Sell
2,184
-34
-2% -$5.63K 0.3% 35
2024
Q1 		$404K Sell
2,218
-334
-13% -$57.6K 0.31% 33
2023
Q4 		$395K Buy
+2,552
New +$372K 0.32% 40

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Priebe Wealth Holdings's ABBV Position: Q2 2025 in Review

Priebe Wealth Holdings reduced its AbbVie (ABBV) stake by 11% in Q2 2025, selling an estimated $67.5K and leaving 2,923 shares worth $543K. The position accounts for 0.47% of the portfolio, ranked #37.

Priebe Wealth Holdings first reported a position in ABBV in Q4 2023 and has held it in 7 quarters since. The position peaked at $688K in Q1 2025. 3,781 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Priebe Wealth Holdings held 2,923 shares of AbbVie worth $543K as of Q2 2025.
  • Priebe Wealth Holdings sold 363 AbbVie shares in Q2 2025, an estimated $67.5K.
  • AbbVie made up 0.47% of Priebe Wealth Holdings's portfolio in Q2 2025, its #37 holding.
  • Priebe Wealth Holdings first reported a position in AbbVie in Q4 2023 and has held it in 7 quarters since.
  • Priebe Wealth Holdings's AbbVie position peaked at $688K in Q1 2025.
  • 3,781 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Priebe Wealth Holdings's 13F filing for Q2 2025, filed 25 Jul 2025.